BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29926137)

  • 1. Radiomics and radiogenomics of prostate cancer.
    Smith CP; Czarniecki M; Mehralivand S; Stoyanova R; Choyke PL; Harmon S; Turkbey B
    Abdom Radiol (NY); 2019 Jun; 44(6):2021-2029. PubMed ID: 29926137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiogenomics in prostate cancer evaluation.
    Thenault R; Gasmi A; Khene ZE; Bensalah K; Mathieu R
    Curr Opin Urol; 2021 Jul; 31(4):424-429. PubMed ID: 34009176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
    Ferro M; de Cobelli O; Vartolomei MD; Lucarelli G; Crocetto F; Barone B; Sciarra A; Del Giudice F; Muto M; Maggi M; Carrieri G; Busetto GM; Falagario U; Terracciano D; Cormio L; Musi G; Tataru OS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review.
    Horvat N; Bates DDB; Petkovska I
    Abdom Radiol (NY); 2019 Nov; 44(11):3764-3774. PubMed ID: 31055615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
    Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
    J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of radiomics in prostate cancer radiotherapy.
    Delgadillo R; Ford JC; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
    Strahlenther Onkol; 2020 Oct; 196(10):900-912. PubMed ID: 32821953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics and radiogenomics for precision radiotherapy.
    Wu J; Tha KK; Xing L; Li R
    J Radiat Res; 2018 Mar; 59(suppl_1):i25-i31. PubMed ID: 29385618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background, current role, and potential applications of radiogenomics.
    Pinker K; Shitano F; Sala E; Do RK; Young RJ; Wibmer AG; Hricak H; Sutton EJ; Morris EA
    J Magn Reson Imaging; 2018 Mar; 47(3):604-620. PubMed ID: 29095543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiogenomics influence on the future of prostate cancer risk stratification.
    Banerjee V; Wang S; Drescher M; Russell R; Siddiqui MM
    Ther Adv Urol; 2022; 14():17562872221125317. PubMed ID: 36160762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of radiomics on prostate cancer detection: a systematic review of clinical applications.
    Sugano D; Sanford D; Abreu A; Duddalwar V; Gill I; Cacciamani GE
    Curr Opin Urol; 2020 Nov; 30(6):754-781. PubMed ID: 32941257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer radiomics and the promise of radiogenomics.
    Stoyanova R; Takhar M; Tschudi Y; Ford JC; Solórzano G; Erho N; Balagurunathan Y; Punnen S; Davicioni E; Gillies RJ; Pollack A
    Transl Cancer Res; 2016 Aug; 5(4):432-447. PubMed ID: 29188191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiogenomics and Radiomics in Liver Cancers.
    Saini A; Breen I; Pershad Y; Naidu S; Knuttinen MG; Alzubaidi S; Sheth R; Albadawi H; Kuo M; Oklu R
    Diagnostics (Basel); 2018 Dec; 9(1):. PubMed ID: 30591628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics/Radiogenomics in Lung Cancer: Basic Principles and Initial Clinical Results.
    Anagnostopoulos AK; Gaitanis A; Gkiozos I; Athanasiadis EI; Chatziioannou SN; Syrigos KN; Thanos D; Chatziioannou AN; Papanikolaou N
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining molecular and imaging metrics in cancer: radiogenomics.
    Lo Gullo R; Daimiel I; Morris EA; Pinker K
    Insights Imaging; 2020 Jan; 11(1):1. PubMed ID: 31901171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entering an era of radiogenomics in prostate cancer risk stratification.
    Soodana-Prakash N; Stoyanova R; Bhat A; Velasquez MC; Kineish OE; Pollack A; Parekh DJ; Punnen S
    Transl Androl Urol; 2018 Sep; 7(Suppl 4):S443-S452. PubMed ID: 30363524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiogenomics: bridging imaging and genomics.
    Bodalal Z; Trebeschi S; Nguyen-Kim TDL; Schats W; Beets-Tan R
    Abdom Radiol (NY); 2019 Jun; 44(6):1960-1984. PubMed ID: 31049614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI and radiomics in prostate cancer: a review.
    Sun Y; Reynolds HM; Parameswaran B; Wraith D; Finnegan ME; Williams S; Haworth A
    Australas Phys Eng Sci Med; 2019 Mar; 42(1):3-25. PubMed ID: 30762223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Role and Translation of Radiomics and Radiogenomics in Adult and Pediatric Neuro-Oncology.
    Ak M; Toll SA; Hein KZ; Colen RR; Khatua S
    AJNR Am J Neuroradiol; 2022 Jun; 43(6):792-801. PubMed ID: 34649914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research Progress of Magnetic Resonance Imaging-based Radiomics in Prostate Cancer].
    Zhang JH; Xu LL; Zhang GM; Sun H; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):123-129. PubMed ID: 35300774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Radio-oncomics" : The potential of radiomics in radiation oncology.
    Peeken JC; Nüsslin F; Combs SE
    Strahlenther Onkol; 2017 Oct; 193(10):767-779. PubMed ID: 28687979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.